GAMB (GAMB) Stock Price & Analysis
GAMB (GAMB) rose 0.41% to USD 2.43 as of June 10, 2026 at 02:24 UTC, according to Nexqual real-time market data.
GAMB last closed at USD 2.42; the session ranged USD 2.4–2.52 on volume of 864,941 shares. Market capitalization is $85.65M, with a 52-week range of USD 2.23–12.74 (NGM). Source: Nexqual, June 10, 2026 at 02:24 UTC.
Key Statistics (as of June 10, 2026 at 02:24 UTC)
| Price | USD 2.43 |
|---|---|
| Change | ▲ 0.41% (up) |
| Previous Close | USD 2.42 |
| Open | USD 2.42 |
| Day Range | USD 2.4 – 2.52 |
| 52-Week Range | USD 2.23 – 12.74 |
| Volume | 864,941 shares |
| Market Cap | $85.65M |
| Exchange | NGM |
Technical Analysis (GAMB)
Nexqual's technical model rates GAMB "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 02:24 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 36.34 (neutral) |
| vs SMA50 | Below (USD 3.37) |
| MACD | -0.34 (negative) |
Analyst Ratings (GAMB)
Wall Street analysts rate GAMB "Buy" based on 7 analysts, with a mean price target of USD 5.43 (range USD 4–6), per Nexqual as of June 10, 2026 at 02:24 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 7 |
| Mean Target | USD 5.43 |
| High Target | USD 6 |
| Low Target | USD 4 |
| Buy / Hold / Sell | 6 / 2 / 0 |
Earnings (GAMB)
| Next Earnings Date | 2026-08-13 |
|---|---|
| EPS Estimate | USD 0.03 |
| Revenue Estimate | $37.48M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 0.09 vs est 0.12 ▼ miss |
| 2025-12-31 | USD 0.3 vs est 0.2 ▲ beat |
| 2025-09-30 | USD 0.26 vs est 0.16 ▲ beat |
| 2025-06-30 | USD 0.37 vs est 0.15 ▲ beat |
Source: Nexqual, June 10, 2026 at 02:24 UTC.
Financials & Fundamentals (GAMB)
| Total Revenue | $165.25M |
|---|---|
| Revenue Growth (YoY) | -0.50% |
| Gross Margin | +88.44% |
| Operating Margin | +8.96% |
| Profit Margin | -27.44% |
| ROE | -35.62% |
| Debt / Equity | 112.84 |
| Current Ratio | 1.31 |
| Total Cash | $8.96M |
| Total Debt | $120.91M |
| Free Cash Flow | $10.64M |
Source: Nexqual, June 10, 2026 at 02:24 UTC.
Financial Health Score (GAMB)
Nexqual rates GAMB's overall financial health "Solid" across five dimensions, as of June 10, 2026 at 02:24 UTC.
| Growth | Strong — Revenue +30% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 88%, operating 9% |
| Balance Sheet | Mixed — $9M cash vs $121M debt |
| Cash Flow | Solid — FCF $11M, 6% margin |
| Efficiency | Critical — ROE -36%, ROA 6.0% |
Ownership (GAMB)
| Insider Ownership | +37.87% |
|---|---|
| Institutional Ownership | +40.20% |
| Shares Outstanding | 35.25M |
| Float | 19.40M |
| Short % of Float | +8.46% |
Source: Nexqual, June 10, 2026 at 02:24 UTC.
Leadership (GAMB)
GAMB is led by Charles Hanson Gillespie (age 42), Co-Founder, CEO & Chairman of the Board, per Nexqual as of June 10, 2026 at 02:24 UTC.
| Co-Founder, CEO & Chairman of the Board | Charles Hanson Gillespie (age 42) |
|---|---|
| Co-Founder, COO & Director | Kevin McCrystle (age 42) |
| Chief Financial Officer | Elias Mark (age 45) |
| Vice President of Investor Relations | Peter McGough |
| Senior Vice President of People | Ellen Monaghan (age 40) |
Major Backers & Investors (GAMB)
Notable institutional backers of GAMB include AWM Investment Company, Inc., ClearBridge Investments, LLC, Morgan Stanley, according to Nexqual as of June 10, 2026 at 02:24 UTC.
Active Investors
| Investor | Stake |
|---|---|
| AWM Investment Company, Inc. | 7.08% |
| ClearBridge Investments, LLC | 1.85% |
| Morgan Stanley | 1.83% |
| Legg Mason Global Asset Management Trust-ClearBridge Small Cap Fund | 1.78% |
| Prescott Group Capital Management, L.L.C. | 1.22% |
| Goldman Sachs | 1.2% |
| UBS Group AG | 0.98% |
| Millennium Management | 0.9% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 4.85% |
Source: Nexqual, June 10, 2026 at 02:24 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| XPOF | Xponential Fitness, Inc. | USD 5.72 | ▲ 7.12% |
| AIRS | AirSculpt Technologies, Inc. | USD 5.28 | ▲ 3.33% |
| JBIO | Jade Biosciences, Inc. | USD 15.22 | ▼ 10.15% |
| HRMY | Harmony Biosciences Holdings, I | USD 34.1 | ▲ 5.9% |
| RSI | Rush Street Interactive, Inc. | USD 27.59 | ▲ 5.55% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 02:24 UTC. This page is informational and not investment advice.